COSMOS Pharmaceutical Corporation (TYO:3349)
6,831.00
-6.00 (-0.09%)
Feb 19, 2025, 3:30 PM JST
COSMOS Pharmaceutical Revenue
COSMOS Pharmaceutical had revenue of 244.10B JPY in the quarter ending November 30, 2024, with 3.97% growth. This brings the company's revenue in the last twelve months to 994.50B, up 10.49% year-over-year. In the fiscal year ending May 31, 2024, COSMOS Pharmaceutical had annual revenue of 964.99B with 16.59% growth.
Revenue (ttm)
994.50B
Revenue Growth
+10.49%
P/S Ratio
0.56
Revenue / Employee
180.42M
Employees
5,512
Market Cap
558.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2024 | 964.99B | 137.29B | 16.59% |
May 31, 2023 | 827.70B | 72.28B | 9.57% |
May 31, 2022 | 755.41B | 28.99B | 3.99% |
May 31, 2021 | 726.42B | 42.02B | 6.14% |
May 31, 2020 | 684.40B | 73.27B | 11.99% |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
May 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |